mhurhangee/ep-ind-claims huggingface dataset:
A plasma-generating device comprising: a pair of electrodes configured to generate plasma by electrical discharge; a power source device configured to generate power to be supplied to the pair of electrodes; a pair of cables (41, 42) configured to transmit the power from the power source device to the pair of electrodes; a conductive shield member configured to shield the pair of cables (41, 42); a ground cable configured to ground the shield member; a detector configured to detecting a current flowing through the ground cable; and a reporting section configured to report a current abnormality in response to the detection by the detector of a current equal to or greater than a predetermined value, wherein. a control section configured to cause the power source device to stop supplying the power in response to the detector detecting a current equal to or greater than the predetermined value, and a supply device (111, 112) configured to supply a processing gas between the pair of electrodes, wherein the control section is configured to stop the supply of the processing gas by the supply device (111, 112) in response to the detector detecting a current equal to or greater than the predetermined value characterized by: a heater configured to heat the processing gas, wherein the control section is configured to cause the heater to stop heating the processing gas in response to the detector detecting a current equal to or greater than the predetermined value. a pair of electrodes configured to generate plasma by electrical discharge; a power source device configured to generate power to be supplied to the pair of electrodes; a pair of cables (41, 42) configured to transmit the power from the power source device to the pair of electrodes; a conductive shield member configured to shield the pair of cables (41, 42); a ground cable configured to ground the shield member; a detector configured to detecting a current flowing through the ground cable; and a reporting section configured to report a current abnormality in response to the detection by the detector of a current equal to or greater than a predetermined value, wherein. a control section configured to cause the power source device to stop supplying the power in response to the detector detecting a current equal to or greater than the predetermined value, and a supply device (111, 112) configured to supply a processing gas between the pair of electrodes, wherein the control section is configured to stop the supply of the processing gas by the supply device (111, 112) in response to the detector detecting a current equal to or greater than the predetermined value characterized by: a heater configured to heat the processing gas, wherein the control section is configured to cause the heater to stop heating the processing gas in response to the detector detecting a current equal to or greater than the predetermined value. a heater configured to heat the processing gas, wherein the control section is configured to cause the heater to stop heating the processing gas in response to the detector detecting a current equal to or greater than the predetermined value.
A method of performing concurrent transactions comprising: creating a first copy of at least one data segment of a committed version of a data page to the space of a first transaction; creating a second copy of the least one data segment of the committed version of a data page to the space of a second transaction; applying, by the first transaction, one or more changes to the first copy of the at least one data segment; committing, by the first transaction, the change to the first copy of the at least one data segment to the committed version of the data page, causing the at least one data segment of the committed version of the data page to be updated with the change; based on the first transaction, committing the change to the first copy of the at least one data segment; detecting (730; 930) that the second copy of the at least one data segment should be automatically updated in order to preserve atomicity, consistency, isolation, and durability standards of the second transaction; and automatically updating the second copy of the at least one data segment with the at least one data segment of the committed version of the data page that has been updated with the changes by the first transaction. creating a first copy of at least one data segment of a committed version of a data page to the space of a first transaction; creating a second copy of the least one data segment of the committed version of a data page to the space of a second transaction; applying, by the first transaction, one or more changes to the first copy of the at least one data segment; committing, by the first transaction, the change to the first copy of the at least one data segment to the committed version of the data page, causing the at least one data segment of the committed version of the data page to be updated with the change; based on the first transaction, committing the change to the first copy of the at least one data segment; detecting (730; 930) that the second copy of the at least one data segment should be automatically updated in order to preserve atomicity, consistency, isolation, and durability standards of the second transaction; and automatically updating the second copy of the at least one data segment with the at least one data segment of the committed version of the data page that has been updated with the changes by the first transaction.
An applicator device comprising: a housing having a reservoir for containing a cosmetic or medicinal product; and an applicator tip assembly comprising: a main body portion coupled to the housing and comprising a product delivery passageway extending through the main body portion to convey the cosmetic or medicinal product, and a thermal storage applicator portion coupled to the main body portion and enclosed by the main body portion at a periphery of the thermal storage applicator portion, the thermal storage applicator portion having an application face for applying the cosmetic or medicinal product to a surface. a housing having a reservoir for containing a cosmetic or medicinal product; and an applicator tip assembly comprising: a main body portion coupled to the housing and comprising a product delivery passageway extending through the main body portion to convey the cosmetic or medicinal product, and a thermal storage applicator portion coupled to the main body portion and enclosed by the main body portion at a periphery of the thermal storage applicator portion, the thermal storage applicator portion having an application face for applying the cosmetic or medicinal product to a surface. a main body portion coupled to the housing and comprising a product delivery passageway extending through the main body portion to convey the cosmetic or medicinal product, and a thermal storage applicator portion coupled to the main body portion and enclosed by the main body portion at a periphery of the thermal storage applicator portion, the thermal storage applicator portion having an application face for applying the cosmetic or medicinal product to a surface.
A load abnormality detection device comprising: a current input unit for detecting and inputting current of an electric motor; an FFT analysis unit for analyzing a power spectrum of the current when the current from the current input unit is in a stable state; a peak detection calculation unit for detecting a peak of the power spectrum obtained by the FFT analysis unit; an averaging calculation unit for averaging a plurality of power spectrums analyzed by the FFT analysis unit; a sideband wave extraction unit for extracting a sideband wave of a power spectrum obtained as a result of the averaging performed by the averaging calculation unit; and a spectrum peak series determination unit for determining an abnormality when the number of peak parts or positional relationship of a spectrum peak series of the sideband wave extracted by the sideband wave extraction unit is different from that of a spectrum peak series of a sideband wave in a normal time. a current input unit for detecting and inputting current of an electric motor; an FFT analysis unit for analyzing a power spectrum of the current when the current from the current input unit is in a stable state; a peak detection calculation unit for detecting a peak of the power spectrum obtained by the FFT analysis unit; an averaging calculation unit for averaging a plurality of power spectrums analyzed by the FFT analysis unit; a sideband wave extraction unit for extracting a sideband wave of a power spectrum obtained as a result of the averaging performed by the averaging calculation unit; and a spectrum peak series determination unit for determining an abnormality when the number of peak parts or positional relationship of a spectrum peak series of the sideband wave extracted by the sideband wave extraction unit is different from that of a spectrum peak series of a sideband wave in a normal time.
Method for modernizing an existing serviette production machine for treating absorbent sheets of material for serviettes, in particular tissue webs or air-laid webs, with a sheet running path, wherein the serviette production machine has at least one feeding section, in particular comprising an unwinding station, a flexographic printing unit and a final treatment station with at least one register-dependent device (14, 15, 16), characterized by the following converting method steps: - separating the feeding section from the final treatment station, - creating a clearance between the feeding section and the final treatment station, - installing a digital printing unit within the clearance, - and establishing a control link from the at least one register-dependent device (14, 15, 16) to the printing controller of the digital printing unit. - separating the feeding section from the final treatment station, - creating a clearance between the feeding section and the final treatment station, - installing a digital printing unit within the clearance, - and establishing a control link from the at least one register-dependent device (14, 15, 16) to the printing controller of the digital printing unit.
A cutting and splitting machine comprising: a machine housing, a cutting section arranged in the housing and further comprising a circular saw for cutting sawlog into pieces, a splitting section comprising: - a pair of vertical guides mounted on the housing on each side of the splitter trough, - a vertically movable rectangular frame provided with splitting knives for splitting pieces of sawlog into chopped wood and arranged in the guides, - at least one hydraulic cylinder to move the rectangular frame with the splitting knives in the guides, - a fixed guard mounted directly on the rectangular frame with the splitting knives below its outer bottom edge, characterized in that the splitting section further comprises a movable guard telescopically movably connected to the fixed guard. a machine housing, a cutting section arranged in the housing and further comprising a circular saw for cutting sawlog into pieces, a splitting section comprising: - a pair of vertical guides mounted on the housing on each side of the splitter trough, - a vertically movable rectangular frame provided with splitting knives for splitting pieces of sawlog into chopped wood and arranged in the guides, - at least one hydraulic cylinder to move the rectangular frame with the splitting knives in the guides, - a fixed guard mounted directly on the rectangular frame with the splitting knives below its outer bottom edge, - a pair of vertical guides mounted on the housing on each side of the splitter trough, - a vertically movable rectangular frame provided with splitting knives for splitting pieces of sawlog into chopped wood and arranged in the guides, - at least one hydraulic cylinder to move the rectangular frame with the splitting knives in the guides, - a fixed guard mounted directly on the rectangular frame with the splitting knives below its outer bottom edge, characterized in that the splitting section further comprises a movable guard telescopically movably connected to the fixed guard.
A compound of formula wherein R 1 is selected from the group consisting of phenyl, -(C 1-2 alkyl)-phenyl, naphthyl, thienyl, benzofuranyl, benzothienyl, indazolyl, quinolinyl, pyrazolyl and pyridyl; wherein the phenyl, naphthyl, thienyl, benzofuranyl, benzothienyl, indazolyl, quinolinyl, pyrazolyl or pyridyl whether alone or as part of a substituent group is optionally substituted with one to more substituents independently selected from the group consisting of halogen, C 1-6 alkyl, fluorinated C 1-4 alkyl, C 1-4 alkoxy and fluorinated C 1-4 alkoxy; a is in integer from 0 to 2; each R 2 is independently selected from the group consisting of halogen, C 1-4 alkyl, fluorinated C 1-4 alkyl, C 1-4 alkoxy and fluorinated C 1-4 alkoxy; R 4 is selected from the group consisting of C 1-6 alkyl, fluorinated C 1-6 alkyl, -(C 1-2 alkyl)-O-(C 1-4 alkyl), C 3-6 cycloalkyl, -(C 1-2 alkyl)-C 3-6 cycloalkyl, phenyl and-(C 1-2 alkyl)-phenyl; wherein the phenyl, whether alone or as part of a substituent group is optionally substituted with one or more substituents independently selected from the group consisting of halogen, C 1-6 alkyl, fluorinated C 1-6 alkyl, C 1-4 alkoxy and fluorinated C 1-4 alkoxy; Z is selected from the group consisting of C and N; or a stereoisomer or pharmaceutically acceptable salt thereof. R 1 is selected from the group consisting of phenyl, -(C 1-2 alkyl)-phenyl, naphthyl, thienyl, benzofuranyl, benzothienyl, indazolyl, quinolinyl, pyrazolyl and pyridyl; wherein the phenyl, naphthyl, thienyl, benzofuranyl, benzothienyl, indazolyl, quinolinyl, pyrazolyl or pyridyl whether alone or as part of a substituent group is optionally substituted with one to more substituents independently selected from the group consisting of halogen, C 1-6 alkyl, fluorinated C 1-4 alkyl, C 1-4 alkoxy and fluorinated C 1-4 alkoxy; a is in integer from 0 to 2; each R 2 is independently selected from the group consisting of halogen, C 1-4 alkyl, fluorinated C 1-4 alkyl, C 1-4 alkoxy and fluorinated C 1-4 alkoxy; R 4 is selected from the group consisting of C 1-6 alkyl, fluorinated C 1-6 alkyl, -(C 1-2 alkyl)-O-(C 1-4 alkyl), C 3-6 cycloalkyl, -(C 1-2 alkyl)-C 3-6 cycloalkyl, phenyl and-(C 1-2 alkyl)-phenyl; wherein the phenyl, whether alone or as part of a substituent group is optionally substituted with one or more substituents independently selected from the group consisting of halogen, C 1-6 alkyl, fluorinated C 1-6 alkyl, C 1-4 alkoxy and fluorinated C 1-4 alkoxy; Z is selected from the group consisting of C and N; or a stereoisomer or pharmaceutically acceptable salt thereof.
A method for mode selection for a communications session, the method being performed by a first device, comprising: transmitting, to a second device, an initial transmit packet of a communications session, said initial transmit packet indicating at least two modes of operation configurable by the first device during the communications session; and receiving, from the second device, an initial receive packet of the communications session, said initial receive packet indicating one of said at least two modes of operation configurable by the second device during the communications session by being transmitted from the second device using said one of said at least two modes of operation. transmitting, to a second device, an initial transmit packet of a communications session, said initial transmit packet indicating at least two modes of operation configurable by the first device during the communications session; and receiving, from the second device, an initial receive packet of the communications session, said initial receive packet indicating one of said at least two modes of operation configurable by the second device during the communications session by being transmitted from the second device using said one of said at least two modes of operation.
A broadband digital trunking service implementation method, said method comprising: a trunking scheduling management center receiving a trunking call establishment request carrying group information; said trunking scheduling management center sending a network side a creating trunking bearer request carrying call information and a transmission bearer address according to said trunking call establishment request; characterized in that: wherein said trunking scheduling management center sending said network side said creating trunking bearer request carrying said call information and said transmission bearer address based on said trunking call establishment request, comprising: said trunking scheduling management center, according to said group information carried in said trunking call establishment request, determining a playback feature of single call or group call of a trunking service at said network side and attributes of a user's role in said single call or group call of said trunking service, and sending said network side said creating trunking bearer request carrying said call information and said transmission bearer address; wherein the playback feature comprises a unicast or multicast mode, the attributes of the user's role comprise whether the user is a calling or called party. a trunking scheduling management center receiving a trunking call establishment request carrying group information; said trunking scheduling management center sending a network side a creating trunking bearer request carrying call information and a transmission bearer address according to said trunking call establishment request; characterized in that: wherein said trunking scheduling management center sending said network side said creating trunking bearer request carrying said call information and said transmission bearer address based on said trunking call establishment request, comprising: said trunking scheduling management center, according to said group information carried in said trunking call establishment request, determining a playback feature of single call or group call of a trunking service at said network side and attributes of a user's role in said single call or group call of said trunking service, and sending said network side said creating trunking bearer request carrying said call information and said transmission bearer address; wherein the playback feature comprises a unicast or multicast mode, the attributes of the user's role comprise whether the user is a calling or called party. said trunking scheduling management center, according to said group information carried in said trunking call establishment request, determining a playback feature of single call or group call of a trunking service at said network side and attributes of a user's role in said single call or group call of said trunking service, and sending said network side said creating trunking bearer request carrying said call information and said transmission bearer address; wherein the playback feature comprises a unicast or multicast mode, the attributes of the user's role comprise whether the user is a calling or called party.
Esketamine for use in a method for the treatment of depression in a patient carrying the G or T allele at SNP rs4306882 comprising: Step A: genetically testing (or genotyping) a patient suffering from depression to determine the patient's genotype at rs4306882; Step B: (i) wherein if the patient carries the G allele at SNP rs4306882, esketamine is administered intranasally to said patient at a dosage of about 28 mg to about 32 mg, one to three times per week for up to eight weeks, or (ii) wherein if the patient carries the T allele at SNP rs4306882, esketamine is administered intranasally to said patient at a dosage of about 28 mg to about 32 mg, two to five times per week for up to eight weeks. Step A: genetically testing (or genotyping) a patient suffering from depression to determine the patient's genotype at rs4306882; Step B: (i) wherein if the patient carries the G allele at SNP rs4306882, esketamine is administered intranasally to said patient at a dosage of about 28 mg to about 32 mg, one to three times per week for up to eight weeks, or (ii) wherein if the patient carries the T allele at SNP rs4306882, esketamine is administered intranasally to said patient at a dosage of about 28 mg to about 32 mg, two to five times per week for up to eight weeks. (i) wherein if the patient carries the G allele at SNP rs4306882, esketamine is administered intranasally to said patient at a dosage of about 28 mg to about 32 mg, one to three times per week for up to eight weeks, or (ii) wherein if the patient carries the T allele at SNP rs4306882, esketamine is administered intranasally to said patient at a dosage of about 28 mg to about 32 mg, two to five times per week for up to eight weeks.
An inkjet printing apparatus (10, 10', 10", 100, 100') for printing ultraviolet curable ink, comprising: a printhead assembly for printing the UV curable ink on a substrate; a UV radiation source for pinning the UV curable ink printed on the surface of the substrate; a liquid coating unit for dispensing a liquid coating on the printed and pinned UV curable ink (12, 12'), the liquid coating preventing contact between atmospheric oxygen and the printed and pinned UV curable ink (12, 12'), wherein the liquid of the liquid coating is transparent to UV radiation so that the printed and pinned UV curable ink underneath the liquid coating can be fully cured while the liquid coating remains coated on the UV curable ink; an ink curing unit for fully curing the printed, pinned, and coated UV curable ink (12, 12'); and the liquid that is transparent to UV radiation contained in the liquid coating unit. a printhead assembly for printing the UV curable ink on a substrate; a UV radiation source for pinning the UV curable ink printed on the surface of the substrate; a liquid coating unit for dispensing a liquid coating on the printed and pinned UV curable ink (12, 12'), the liquid coating preventing contact between atmospheric oxygen and the printed and pinned UV curable ink (12, 12'), wherein the liquid of the liquid coating is transparent to UV radiation so that the printed and pinned UV curable ink underneath the liquid coating can be fully cured while the liquid coating remains coated on the UV curable ink; an ink curing unit for fully curing the printed, pinned, and coated UV curable ink (12, 12'); and the liquid that is transparent to UV radiation contained in the liquid coating unit.
A method of producing a carbonyl compound by a flow type reaction, comprising: introducing a triphosgene solution into a flow channel, bringing the triphosgene solution into contact with a solid catalyst immobilized in at least a part of the flow channel to generate a phosgene solution while the triphosgene solution is flowing through the flow channel, joining the phosgene solution and an active hydrogen-containing compound solution that flows inside a flow channel, which are subsequently allowed to flow downstream inside a reaction flow channel to be reacted in a presence of a tertiary amine, and obtaining a carbonyl compound in the joining solution; wherein the tertiary amine includes amines in which all three bonding sites of the nitrogen atom are bonded to an atom other than a hydrogen atom.